Explore Our Affordable Courses

Click Here

Jardiance (Empagliflozin): A News Drug for Chronic Kidney Disease

February 16, 2024

Context:

Recently, CDSCO has approved Boehringer Ingelheim’s anti-diabetic drug for the treatment of Chronic kidney disease in India.

Central Drugs Standard Control Organization (CDSCO)

It is the National Regulatory Authority (NRA) of India regulates the quality, safety, and efficacy of drugs including vaccines & the medical devices industry.
Regulation: Drugs & Cosmetics Act 1940 & New Drugs and Clinical Trials Rules, 2019.
Nodal Ministry: Ministry of Health & Family Welfare.
Headed by: Drugs Controller General of India (DCGI)
Headquarters: New Delhi.

What Is Chronic Kidney Disease (CKD)?

It means when kidneys are damaged and can’t filter blood the way they should.
Main Risk factors: Diabetes, High Blood Pressure, Heart disease, and a family history of kidney failure.
CKD Burden in India: An estimated 33 million adults live with CKD in India.

About Jardiance Drug Efficacy

Reduce the risk of sustained decline in estimated glomerular filtration rate (eGFR) which is done to check how well the kidneys are filtering, and end-stage kidney disease.
Reduce Cardiovascular death (Earlier, it was approved only for the treatment of heart failure.)
Reduce Hospitalization of Adults with CKD.

Also Read: Casgevy And Lyfgenia: CRISPR-Based Gene Therapies

News Source: Live Mint

Must Read
NCERT Notes For UPSC	UPSC Daily Current Affairs
UPSC Blogs	UPSC Daily Editorials
Daily Current Affairs Quiz	Daily Main Answer Writing
UPSC Mains Previous Year Papers	UPSC Test Series 2024

To get PDF version, Please click on "Print PDF" button.

Recent Post
Most Viewed Post

Supreme Court On Bulldozer Justice

Biodegradable Nanocoating for Fertilizers

Supreme Court Ruling on Pollution-Free Environment and Firec...

Jawahar Lal Nehru

World Diabetes Day

First India-U.S., Indian Ocean Dialogue

Social Stock Exchange

Data Point

Arsenic and Fluoride In Groundwater

WHO Launches ICD 11 – A Traditional Medicine Module 2:...

Prime- Minister’s Egypt State Visit

Drug Controller General of India

Recent Editorial

Manipur’s misery: On the need for the Centre...

The perfect cocktail of layered discrimination

A highway to tap Southeast Asian markets

The Taboo of Divorce is Waning, But Families are S...

India Needs to Build Ships

A Mixed Report Card for the India-Middle East-Euro...

Popular current affairs

Supreme Court On Bulldozer Justice

Biodegradable Nanocoating for Fertilizers

Supreme Court Ruling on Pollution-Free Environment...

Jawahar Lal Nehru

World Diabetes Day

First India-U.S., Indian Ocean Dialogue

Our Courses

Our Courses

Need help preparing for UPSC or State PSCs?

Connect with our experts to get free counselling & start preparing

THE MOST
LEARNING PLATFORM

Learn From India's Best Faculty

Subscribe our Newsletter

Sign up now for our exclusive newsletter and be the first to know about our latest Initiatives, Quality Content, and much more.

*Promise! We won't spam you.

Yes! I want to Subscribe.

Contact Details

THE MOST
LEARNING PLATFORM

Learn From India's Best Faculty

Follow Us:

Subscribe our Newsletter

Sign up now for our exclusive newsletter and be the first to know about our latest Initiatives, Quality Content, and much more.

*Promise! We won't spam you.

Yes! I want to Subscribe.

Contact Details

Download Our App